DNA methylation age acceleration mediates the relationship between systemic inflammation and cognitive impairment
Authors:
- César Higgins TejeraCTCésar Higgins Tejera
- Peiyao ZhuPZPeiyao Zhu
- Erin B. WareEWErin B. Ware
- Margaret T. HickenMHMargaret T. Hicken
- Matthew ZawistowskiMZMatthew Zawistowski
- Lindsay C. KobayashiLKLindsay C. Kobayashi
- Dominika SeblovaDSDominika Seblova
- Jennifer ManlyJMJennifer Manly
- Bhramar MukherjeeBMBhramar Mukherjee
- Kelly M. BakulskiKBKelly M. Bakulski
Open Access
- 8 December 2025
- journal article
- Published by Taylor & Francis in Epigenomics
- Vol. 17 (18) , 1399-1409
Abstract
Chronic inflammation and DNA methylation are potential mechanisms in dementia etiology. The linkage between inflammation and DNA methylation age acceleration in shaping dementia risk remains understudied. We explored the association of inflammatory cytokines with cognitive impairment and whether DNA methylation age acceleration mediates this relationship. Using data from the 2016 Health and Retirement Study (n = 3,346, age >50), we estimate the associations between each inflammatory cytokine (interleukin-6 (IL-6), C-reactive protein (CRP), and insulin-like growth factor-1 (IGF-1)), and cognitive status, classified using the Langa-Weir method. We tested if DNA methylation age acceleration mediated the relationship between systemic inflammation and cognitive impairment, adjusting for sociodemographic, behavioral factors, chronic conditions, and cell-type proportions. Cognitive impairment prevalence was 16%. A doubling of IL-6 was associated with a 12% higher odds of cognitive impairment (OR = 1.12, 95% CI: 1.02-1.22), and 0.77 years of GrimAge acceleration (95% CI: 0.64-0.90). Similar associations were found for CRP and IGF-1. Mediation analysis indicated that 17.7% (95% CI: 7.0-50.9%) of the IL-6-cognitive impairment association was mediated by the GrimAge acceleration. Comparable mediated estimates were found for CRP and IGF-1. Systemic inflammation is associated with cognitive impairment, with suggestive evidence that this relationship is partially mediated through DNA methylation age acceleration.Keywords
Funding Information
- National Institute on Aging (U01 AG009740)
- National Institute on Aging (R01 AG067592)
- National Institute on Aging (R01 AG055406)
- National Institute on Aging (P30 AG072931)
- National Institute on Aging (R01 AG074887)
- University of Michigan Rackham Merit Fellowship program
This publication has 55 references indexed in Scilit:
- Health Behavior Change to Mitigate Dementia Risk: An Updated ReviewCurrent Geriatrics Reports, 2024
- The structural and social determinants of Alzheimer's disease related dementiasAlzheimer's & Dementia, 2023
- A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational StudiesJAMA, 2021
- Immune senescence, epigenetics and autoimmunityClinical Immunology, 2018
- Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's diseaseAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018
- The blood-brain barrier in systemic inflammationBrain, Behavior, and Immunity, 2017
- Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literatureAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016
- The Hallmarks of AgingCell, 2013
- Inflammatory Proteins in Plasma and the Risk of DementiaArchives of Neurology, 2004
- Utility of TICS‐M for the assessment of cognitive function in older adultsInternational Journal of Geriatric Psychiatry, 2003